Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 60,800
-2,600 (-4.10%)
At close: Apr 9, 2026
Next Biomedical Revenue
In the year 2025, Next Biomedical had annual revenue of 16.48B KRW with 72.67% growth. Next Biomedical had revenue of 3.80B in the quarter ending December 31, 2025, with 70.60% growth.
Revenue
16.48B
Revenue Growth
+72.67%
P/S Ratio
33.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
546.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.48B | 6.93B | 72.67% |
| Dec 31, 2024 | 9.54B | 4.66B | 95.46% |
| Dec 31, 2023 | 4.88B | 2.09B | 74.67% |
| Dec 31, 2022 | 2.80B | 527.74M | 23.28% |
| Dec 31, 2021 | 2.27B | 6.63M | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 102.75B |
| JPI Healthcare | 96.93B |
| MEDIANA Co.,Ltd | 64.94B |
| L&K Biomed | 38.92B |
| ASTERASYS Co.,Ltd | 37.94B |
| Hironic | 32.09B |
| SELVAS Healthcare | 30.82B |
| Remed | 24.50B |